Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Language Development Disorders | 11 | 2025 | 14 | 6.270 |
Why?
|
| Multilingualism | 16 | 2025 | 50 | 5.680 |
Why?
|
| Language Tests | 16 | 2025 | 22 | 2.980 |
Why?
|
| Child Language | 9 | 2025 | 14 | 2.820 |
Why?
|
| Vietnam | 15 | 2025 | 61 | 1.620 |
Why?
|
| Vocabulary | 6 | 2021 | 19 | 1.530 |
Why?
|
| Language | 11 | 2023 | 181 | 1.500 |
Why?
|
| Child | 23 | 2025 | 3381 | 1.470 |
Why?
|
| Language Development | 5 | 2025 | 25 | 1.350 |
Why?
|
| Child, Preschool | 13 | 2025 | 1516 | 1.120 |
Why?
|
| Language Therapy | 3 | 2014 | 3 | 0.910 |
Why?
|
| Linguistics | 6 | 2025 | 22 | 0.840 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2024 | 88 | 0.810 |
Why?
|
| Attention | 3 | 2023 | 165 | 0.800 |
Why?
|
| Memory, Short-Term | 2 | 2023 | 56 | 0.800 |
Why?
|
| Caregivers | 1 | 2023 | 195 | 0.660 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 415 | 0.650 |
Why?
|
| Humans | 34 | 2025 | 42163 | 0.620 |
Why?
|
| Reaction Time | 1 | 2019 | 151 | 0.600 |
Why?
|
| Sanitation | 1 | 2018 | 27 | 0.560 |
Why?
|
| Sepsis | 3 | 2023 | 90 | 0.530 |
Why?
|
| Language Disorders | 1 | 2017 | 8 | 0.520 |
Why?
|
| Learning | 2 | 2018 | 155 | 0.500 |
Why?
|
| Education, Special | 2 | 2014 | 12 | 0.440 |
Why?
|
| Emigrants and Immigrants | 2 | 2018 | 156 | 0.420 |
Why?
|
| Public Health | 1 | 2018 | 405 | 0.410 |
Why?
|
| Male | 16 | 2025 | 22779 | 0.410 |
Why?
|
| Female | 16 | 2025 | 24018 | 0.380 |
Why?
|
| Professional-Patient Relations | 1 | 2011 | 60 | 0.340 |
Why?
|
| Verbal Learning | 1 | 2010 | 18 | 0.340 |
Why?
|
| Intensive Care Units | 3 | 2023 | 71 | 0.270 |
Why?
|
| Feasibility Studies | 2 | 2023 | 238 | 0.270 |
Why?
|
| 2,4-Dichlorophenoxyacetic Acid | 1 | 2025 | 2 | 0.240 |
Why?
|
| Ozone | 1 | 2025 | 26 | 0.240 |
Why?
|
| Herbicides | 1 | 2025 | 44 | 0.230 |
Why?
|
| Reproducibility of Results | 2 | 2025 | 1058 | 0.220 |
Why?
|
| Cognition | 3 | 2023 | 458 | 0.210 |
Why?
|
| Pharmacists | 1 | 2024 | 56 | 0.200 |
Why?
|
| Eupatorium | 1 | 2023 | 1 | 0.200 |
Why?
|
| Thymol | 1 | 2023 | 2 | 0.200 |
Why?
|
| Plant Components, Aerial | 1 | 2023 | 5 | 0.200 |
Why?
|
| Water Pollutants, Chemical | 1 | 2025 | 170 | 0.200 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2023 | 44 | 0.200 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 421 | 0.190 |
Why?
|
| Neuropsychological Tests | 2 | 2023 | 281 | 0.190 |
Why?
|
| Adenoviridae Infections | 1 | 2021 | 5 | 0.180 |
Why?
|
| Magnolia | 1 | 2021 | 1 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 276 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 53 | 0.180 |
Why?
|
| Lignans | 1 | 2021 | 22 | 0.180 |
Why?
|
| Health Personnel | 1 | 2024 | 262 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 727 | 0.170 |
Why?
|
| Agriculture | 1 | 2021 | 65 | 0.170 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2020 | 3 | 0.170 |
Why?
|
| Neutropenia | 1 | 2020 | 11 | 0.170 |
Why?
|
| Emotions | 1 | 2023 | 251 | 0.160 |
Why?
|
| Ecosystem | 1 | 2021 | 171 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 479 | 0.150 |
Why?
|
| Neutrophils | 1 | 2020 | 141 | 0.150 |
Why?
|
| Telemedicine | 1 | 2022 | 215 | 0.140 |
Why?
|
| Phonetics | 2 | 2025 | 4 | 0.140 |
Why?
|
| Acoustic Stimulation | 1 | 2018 | 74 | 0.140 |
Why?
|
| Knowledge | 1 | 2018 | 16 | 0.140 |
Why?
|
| Biofuels | 1 | 2018 | 15 | 0.140 |
Why?
|
| Community Health Planning | 1 | 2018 | 38 | 0.140 |
Why?
|
| Smoking Cessation | 1 | 2024 | 583 | 0.140 |
Why?
|
| Narration | 1 | 2017 | 37 | 0.130 |
Why?
|
| Social Environment | 1 | 2018 | 218 | 0.130 |
Why?
|
| California | 1 | 2018 | 531 | 0.130 |
Why?
|
| Interviews as Topic | 1 | 2018 | 428 | 0.130 |
Why?
|
| Program Evaluation | 1 | 2018 | 358 | 0.120 |
Why?
|
| Schools | 1 | 2018 | 283 | 0.120 |
Why?
|
| Focus Groups | 1 | 2018 | 398 | 0.120 |
Why?
|
| Mutation | 1 | 2020 | 1169 | 0.110 |
Why?
|
| Qualitative Research | 1 | 2018 | 526 | 0.110 |
Why?
|
| Cutis Laxa | 1 | 2014 | 1 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1554 | 0.110 |
Why?
|
| Elastin | 1 | 2014 | 40 | 0.110 |
Why?
|
| Point Mutation | 1 | 2014 | 98 | 0.110 |
Why?
|
| Age Factors | 1 | 2017 | 1139 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2014 | 1586 | 0.100 |
Why?
|
| ROC Curve | 2 | 2023 | 157 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2014 | 243 | 0.100 |
Why?
|
| United States | 1 | 2023 | 5072 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1051 | 0.090 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2011 | 4 | 0.090 |
Why?
|
| Speech Perception | 1 | 2011 | 11 | 0.090 |
Why?
|
| Comprehension | 1 | 2011 | 40 | 0.090 |
Why?
|
| Intelligence Tests | 1 | 2010 | 8 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2022 | 206 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2023 | 560 | 0.080 |
Why?
|
| Prognosis | 2 | 2023 | 850 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1020 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 3077 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 602 | 0.070 |
Why?
|
| Reading | 1 | 2008 | 13 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2023 | 722 | 0.070 |
Why?
|
| Mice | 3 | 2023 | 6490 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2023 | 2485 | 0.060 |
Why?
|
| Water Purification | 1 | 2025 | 33 | 0.060 |
Why?
|
| Adult | 4 | 2023 | 13458 | 0.060 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 32 | 0.060 |
Why?
|
| Risk Factors | 2 | 2024 | 3942 | 0.060 |
Why?
|
| Evidence-Based Practice | 1 | 2024 | 48 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2025 | 193 | 0.050 |
Why?
|
| Infant | 1 | 2008 | 1143 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2025 | 448 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2023 | 25 | 0.050 |
Why?
|
| Iron | 1 | 2025 | 247 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2023 | 86 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 68 | 0.050 |
Why?
|
| Circular Dichroism | 1 | 2023 | 64 | 0.050 |
Why?
|
| Acetylcholinesterase | 1 | 2023 | 55 | 0.050 |
Why?
|
| Genomics | 1 | 2024 | 289 | 0.050 |
Why?
|
| Middle Aged | 3 | 2024 | 11819 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 300 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 37 | 0.040 |
Why?
|
| Asia, Southeastern | 1 | 2021 | 12 | 0.040 |
Why?
|
| Indonesia | 1 | 2021 | 22 | 0.040 |
Why?
|
| Thailand | 1 | 2021 | 51 | 0.040 |
Why?
|
| Plant Leaves | 1 | 2021 | 134 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2021 | 268 | 0.040 |
Why?
|
| Animals | 3 | 2023 | 16695 | 0.040 |
Why?
|
| Adolescent | 2 | 2022 | 5950 | 0.040 |
Why?
|
| China | 1 | 2021 | 233 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 104 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2020 | 168 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 378 | 0.040 |
Why?
|
| Candida albicans | 1 | 2020 | 173 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 845 | 0.040 |
Why?
|
| Inflammation | 1 | 2023 | 729 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2021 | 303 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 658 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 557 | 0.030 |
Why?
|
| Heterozygote | 1 | 2014 | 107 | 0.030 |
Why?
|
| Family Health | 1 | 2014 | 56 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2014 | 187 | 0.020 |
Why?
|
| Parents | 1 | 2014 | 359 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 7982 | 0.020 |
Why?
|